Alain D. Baron
Director Ejecutivo en Nazura BioHealth, Inc. .
Origen de la red de primer grado Alain D. Baron.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.
54
| Extinct | Pharmaceuticals: Major | 54 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Alain D. Baron a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of California San Diego | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| DEXCOM, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Compliance Officer Chairman | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Aerami Therapeutics, Inc.
 Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree Doctorate Degree | |
| Duke University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| California Lutheran University | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
| Vanderbilt University | College/University | Undergraduate Degree Masters Business Admin | |
| Purdue University | College/University | Doctorate Degree Doctorate Degree | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| The College of Wooster | College/University | Undergraduate Degree Undergraduate Degree | |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Medical Specialties | Director/Board Member General Counsel | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MIRATI THERAPEUTICS | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Indiana University | College/University | Undergraduate Degree Corporate Officer/Principal | |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal | |
| Rady School of Management at UC San Diego | College/University | Masters Business Admin Masters Business Admin | |
| Syntex Laboratories, Inc. | Sales & Marketing Corporate Officer/Principal | ||
| EQUILLIUM, INC. | Biotechnology | Chief Operating Officer Director of Finance/CFO | |
The San Diego Symphony Orchestra Association
 The San Diego Symphony Orchestra Association Movies/EntertainmentConsumer Services The San Diego Symphony performs and conducts concerts and musical orchestra. It also provides corporate sponsorship, outreach programs, and ticket purchasing services. The company was founded on December 6, 1910 and is headquartered in San Diego, CA. | Movies/Entertainment | Director/Board Member Director/Board Member | |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | President Chief Tech/Sci/R&D Officer | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
AutoGenomics, Inc.
 AutoGenomics, Inc. Medical SpecialtiesHealth Technology AutoGenomics, Inc. engages in the design, development, manufacture, and marketing of an automated, microarray-based multiplexing diagnostic platform. The company was founded by Fareed Kureshy, Shailendra Singh, and Ramanath Vairavan in April 1999 and is headquartered in Carlsbad, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
CardioNet LLC
 CardioNet LLC Medical SpecialtiesHealth Technology CardioNet LLC provides cardiac monitoring services. It operates its business through two segments: Patient Service and Product Business. The Patient Service segment focuses on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, through its core mobile cardiac outpatient telemetry, event and Holter services. The Product Business segment focuses on the development, manufacturing, testing and marketing of medical devices and related software to medical companies, clinics and hospitals. The company was founded by James M. Sweeney in 1999 and is headquartered in Conshohocken, PA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Minnesota Law School | College/University | Director/Board Member Graduate Degree | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Corporate Directors Forum
 Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Compliance Officer Chief Operating Officer |
Estadísticas
Internacional
| Estados Unidos | 51 |
Sectorial
| Health Technology | 30 |
| Consumer Services | 14 |
| Commercial Services | 7 |
| Health Services | 2 |
Operativa
| Director/Board Member | 161 |
| Corporate Officer/Principal | 139 |
| Undergraduate Degree | 49 |
| Independent Dir/Board Member | 44 |
| Chief Tech/Sci/R&D Officer | 38 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Karin Eastham | 29 |
| Julia Brown | 27 |
| Steven Altman | 21 |
| Adrian Adams | 19 |
| Jay Skyler | 18 |
| Mark Foletta | 18 |
| Joseph Sullivan | 17 |
| Teresa Beck | 17 |
| James R. Gavin | 17 |
| Terrance Gregg | 16 |
| Dennis D. Kim | 16 |
| Vaughn D. Bryson | 14 |
| Donald Rindell | 14 |
| Tom R. Testman | 13 |
| Mark Gergen | 13 |
- Bolsa de valores
- Insiders
- Alain D. Baron
- Conexiones Empresas
